Smith D C, Tucker J A, Trump D L
Department of Medicine, Duke University Medical Center, Durham, NC.
J Clin Oncol. 1992 Mar;10(3):499-505. doi: 10.1200/JCO.1992.10.3.499.
Hypercalcemia is a rare complication of prostate cancer, and no definite association with any histologic subtype of prostatic malignancy has been documented. We have recently seen three patients who developed hypercalcemia in the setting of prostate cancer. All had neuroendocrine carcinoma of the prostate (NCPs), which prompted an exploration of the potential association of hypercalcemia with NCP.
An extensive review of literature published in the English-language was conducted to identify cases of hypercalcemia associated with prostate cancer and well-documented cases of NCP.
We found 17 reported cases of hypercalcemia clearly associated with prostate cancer and a total of 61 cases of well-documented NCP. Including our cases, 11 of the 20 reported cases of hypercalcemia associated with prostate carcinoma were in patients with neuroendocrine carcinomas.
Hypercalcemia in the setting of prostate cancer should prompt a search for unusual histologies.
高钙血症是前列腺癌的一种罕见并发症,目前尚无文献记载其与前列腺恶性肿瘤的任何组织学亚型有明确关联。我们最近遇到了三名在前列腺癌背景下发生高钙血症的患者。他们均患有前列腺神经内分泌癌(NCP),这促使我们探究高钙血症与NCP之间的潜在关联。
对英文发表的文献进行了广泛回顾,以确定与前列腺癌相关的高钙血症病例以及有充分记录的NCP病例。
我们发现17例报告的高钙血症病例与前列腺癌明确相关,以及总共61例有充分记录的NCP病例。包括我们的病例在内,20例报告的与前列腺癌相关的高钙血症病例中有11例是神经内分泌癌患者。
前列腺癌患者出现高钙血症应促使寻找不寻常的组织学类型。